Left atrial asynchrony is a major predictor of 1-year recurrence of atrial fibrillation after electrical cardioversion

Journal of Cardiovascular Medicine

Volumn 11, Issue 7, 2010, Pages 499-506

  Rondano, Elisa ^a   Dell'Era, Gabriele ^a   De Luca, Giuseppe ^a   Piccinino, Cristina ^a   Bellomo, Giorgio ^a   Marino, Paolo N ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Asynchrony; Atrial fibrillation; Electrical cardioversion; Left atrium; Strain

Indexed keywords

ANTICOAGULANT AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVERSION; CLINICAL PRACTICE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VOLUME; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; SINUS RHYTHM; ATRIAL FIBRILLATION; CHI SQUARE DISTRIBUTION; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART ATRIUM FUNCTION; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ATRIAL FUNCTION, LEFT; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 77953289905     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32833757b5     Document Type: Article

References (36)

1. Chen LY, Shen WK. Epidemiology of atrial fibrillation: a current perspective. Heart Rhythm 2007; 4 (Suppl):S1-S6.
2. Crijns HJ, Van Gelder IC, Van Gilst WH, Hillege H, Gosselink AM, Lie KI. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991; 68:335-341.
3. Tieleman RG, Van Gelder IC, Crijns HJ, De Kam PJ, Van Den Berg MP, Haaksma J, et al. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodelling of the atria? J Am Coll Cardiol 1998; 31:167-173.
4. Nakao F, Wasaki Y, Kimura M, Iwami T, Iida H, Wakeyama T, et al. Evaluation of left atrial function by the functional volume change curve derived from Doppler flow spectra. Jpn Circ J 2001; 65:953-957.
5. Marino P, Faggian G, Bertolini P, Mazzucco A, Little WC. Early mitral deceleration and left atrial stiffness. Am J Physiol Heart Circ Physiol 2004; 287:H1172-H1178.
6. Corrado G, Klein AL, Santarone M. Echocardiography in atrial fibrillation. J Cardiovasc Med 2006; 7:498-504.
7. Boutjdir M, Le Heuzey JY, Lavergne T, Chauvaud S, Guize L, Carpentier A, et al. Inhomogeneity of cellular refractoriness in human atrium: factor or arrhythmia? Pacing Clin Electrophysiol 1986; 9:1095-1100.
8. Morganroth J, Horowitz LN, Josephson ME, Kastor JA. Relationship of atrial fibrillatory wave amplitude to left atrial size and etiology of heart disease. An old generalization re-examined. Am Heart J 1979; 97:184-186.
9. Sirbu C, Herbots L, D'hooge J, Claus P, Marciniak A, Langeland T, et al. Feasibility of strain and strain rate imaging for the assessment of regional left atrial deformation: a study in normal subjects. Eur J Echocardiogr 2006; 7:199-208.
10. Di Salvo G, Caso P, Lo Piccolo R, Fusco A, Martiniello AR, Russo MG, et al. Atrial myocardial deformation properties predict maintenance of sinus rhythm after external cardioversion of recent-onset lone atrial fibrillation: a color Doppler myocardial imaging and transthoracic and transesophageal echocardiographic study. Circulation 2005; 112:387-395.
11. Sanfilippo AJ, Abascal VM, Sheehan M, Oertel LB, Harrigan P, Hughes RA, et al. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation 1990; 82:792-797.
12. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
13. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by twodimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two- Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Echocardiography 2006; 7:79-108.
15. Helmcke F, Nanda NC, Hsiung MC, Soto B, Adey CK, Goyal RG, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987; 75:175-183.
16. Little WC, Ohno M, Kitzman DW, Thomas JD, Cheng CP. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. Circulation 1995; 92:1933-1939.
17. Marino P, Little WC, Rossi A, Barbieri E, Anselmi M, Destro G, et al. Can left ventricular diastolic stiffness be measured noninvasively? J Am Soc Echocardiogr 2002; 15:935-943.
18. Serri K, Reant P, Lafitte M, Berhouet M, Le Bouffos V, Roudaut R, et al. Global and regional myocardial function quantification by two-dimensional strain. J Am Coll Cardiol 2006; 47:1175-1181.
19. Gantz S. Statistica per discipline biomediche. 5th ed. Italy: McGraw Hill; 2003.
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measuremet. Lancet 1986; 1:307-310.
21. Schlesselman JJ. Case-control studies. New York, NY: Oxford Press; 1982. pp. 203-206.
22. Thomas L, Boyd A, Thomas SP, Schiller NB, Ross DL. Atrial structural remodelling and restoration of atrial contraction after linear ablation for atrial fibrillation. Eur Heart J 2003; 24:1942-1951.
23. Sanders P, Morton JB, Kistler PM, Vohra JK, Kalman JM, Sparks PB. Reversal of atrial mechanical dysfunction after cardioversion of atrial fibrillation: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy. Circulation 2003; 108:1976-1984.
24. Roshanali F, Mandegar MH, Yousefnia MA, Rayatzadeh H, Alaeddini F, Amouzadeh F. Prediction of atrial fibrillation via atrial electromechanical interval after coronary artery bypass grafting. Circulation 2007; 116:2012-2017.
25. Okcun B, Yigit Z, Küçükoglu MS, Mutlu H, Sansoy V, Güzelsoy D, Uner S. Predictors for maintenance of sinus rhythm after cardioversion in patients with nonvalvular atrial fibrillation. Echocardiography 2002; 19:351-357.
26. Antonielli E, Pizzuti A, Pá linkás A, Tanga M, Gruber N, Michelassi C, et al. Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillation. J Am Coll Cardiol 2002; 39:1443-1449.
27. Schneider C, Malisius R, Krause K, Lampe F, Bahlmann E, Boczor S, et al. Strain rate imaging for functional quantification of the left atrium: atrial deformation predicts the maintenance of sinus rhythm after catheter ablation of atrial fibrillation. Eur Heart J 2008; 29:1397-1399.
28. Cho GY, Kim SH, Kim MK, Park WJ, Jo SH, Kim HS, et al. Left atrial dyssynchrony assessed by tissue Doppler and strain imaging in predicting future development of atrial fibrillation in patients with heart failure (abstract). Eur Heart J 2008; 28 (suppl):240.
29. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs. Atrial remodelling of a different sort. Circulation 1999; 10:87-95.
30. Volgman AS, Soble JS, Neumann A, Muktar KN, Iftikhar F, Vallesteros A, et al. Effect of left atrial size on recurrence of atrial fibrillation after electrical cardioversion: atrial dimension versus volume. Am J Card Imaging 1996; 10:261-265.
31. Spach MS, Dolber PC. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscles: evidence of electrical uncoupling of side-to-side fiber connections with increasing age. Circ Res 1986; 58:356-371.
32. Verdecchia P, Reboldi GP, Gattobigio R, Bentivoglio M, Borgioni C, Angeli F, et al. Atrial fibrillation in hypertension. Predictors and outcome. Hypertension 2003; 41:218-223.
33. Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 2003; 107:2926-2931. (Pubitemid 36736634)
34. Maggioni AP, Latini R, Carson PE, Singh SN, Barlera S,Glanzer R, et al. On behalf of Val-HeFT investigators. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). Am Heart J 2005; 149:548-557.
35. Goette A, Staack T, Rocken C, Arndt M, Geller JC, Huth C, et al. Increased expression of extracellular signal-regulated kinase and angiotensinconverting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 2000; 35:1669-1677.
36. Healey JS, Morillo CA, Connolly SJ. Role of the rennin- angiotensinaldosterone system in atrial fibrillation and cardiac remodelling. Curr Opin Cardiol 2005; 20:31.